Exporter of a wide range of products which include lomustine capsule (belustine 40mg capsule), pagenax 120mg injection, tucanat tucatinib 150mg tablets, injectafer 750mg / 15ml injection, peg l-asparaginase injection (lagipeg 750iu injection) and leuprolide injection(bdsure 22.5mg injection).
Divy Tradelink provides a wide range of injectable anti-cancer medications for hospital and clinical oncology use, sourced directly from certified Indian pharmaceutical manufacturers. Our injectable chemotherapy and targeted therapy portfolio includes cytotoxic agents, monoclonal antibodies, and hormone therapies administered intravenously or subcutaneously under medical supervision.
Injectable cancer therapies are typically used for cancers requiring rapid, controlled drug delivery, including breast, lung, ovarian, blood, and various solid tumor cancers. These medications work through diverse mechanisms — from directly damaging cancer cell DNA to blocking the blood vessel formation tumors need to grow, or harnessing the immune system to target malignant cells.
All injectable oncology products are manufactured under strict WHO-GMP and international quality standards, with complete documentation available for export compliance, including product dossiers, stability data, and regulatory certificates required by importing countries. We serve hospitals, oncology centers, and pharmaceutical distributors across international markets with reliable cold-chain logistics where required.
Because injectable cancer therapies require precise handling, storage, and administration protocols, our team works closely with procurement partners to ensure proper documentation, batch traceability, and compliance support throughout the export process. Reach out to discuss bulk pricing, specific product availability, or custom sourcing requests.
